07:58 AM EST, 02/20/2025 (MT Newswires) -- BridgeBio Pharma ( BBIO ) reported a Q4 net loss Thursday of $1.40 per diluted share, compared with a loss of $0.96 a year earlier.

Analysts polled by FactSet expected a loss of $1.13.

Revenue for the quarter ended Dec. 31 was $5.9 million, up from $1.74 million a year earlier.

Analysts surveyed by FactSet expected $3.1 million.

Shares were up more than 6% in recent premarket activity.